Skip to main content

Eric Schmidt

Analyst, Cowen & Company

Analyst — Cowen and Company Analyst — Cantor Analyst — Cantor Fitzgerald Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 Allogene Therapeutics, Inc. (ALLO) $490,000 $5,279,677
2021 Allogene Therapeutics, Inc. (ALLO) $475,000 $3,458,962
2020 Allogene Therapeutics, Inc. (ALLO) $440,000 $2,483,819
2019 Allogene Therapeutics, Inc. (ALLO) $425,000 $3,460,066
2018 Allogene Therapeutics, Inc. (ALLO) $201,232 $2,588,989

Executive changes

Earnings-call appearances